Edition | 200 Verified Questions
APEA 3P Exam Predictor 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously curated for the APEA 3P Exam
Predictor, designed to simulate the actual examination environment and assess clinical readiness.
Featuring 200 verified questions, it covers essential advanced practice nursing concepts, including
differential diagnosis, pharmacology, and patient management. Each question is accompanied by
detailed rationales to reinforce learning and critical thinking. Ideal for nurse practitioners seeking a
high-yield, evidence-based review to ensure success on the 2026/2027 APEA 3P Exam.
Key Features:
Differential Diagnosis and Clinical Reasoning
Pharmacology and Prescriptive Authority
Patient Assessment and Diagnostic Testing
Management of Acute and Chronic Conditions
Health Promotion and Disease Prevention
Ethical and Legal Considerations in Practice
Updates for 2026:
- Aligned with the latest 2026/2027 APEA 3P exam blueprint and guidelines
- Incorporated recent evidence-based practice updates and clinical guidelines
- Enhanced rationales with expanded explanations for correct and incorrect options
- Added new questions reflecting emerging healthcare trends and topics
- Revised content to ensure accuracy and relevance to current advanced practice nursing
Abstract:
This exam preparation document is a definitive resource for advanced practice nursing candidates preparing for
the APEA 3P Exam Predictor. It comprises 200 rigorously verified questions that mirror the format, difficulty, and
content distribution of the actual exam. The document is organized into key content areas, each with a specified
weight, allowing for targeted study. Detailed rationales accompany every question, providing a comprehensive
review of the underlying concepts and clinical reasoning. Updated for the 2026/2027 academic year, this document
integrates the latest clinical guidelines and evidence-based practices, ensuring that candidates are well-prepared
to demonstrate their competence. The structured approach, combined with high-yield content, makes this an
indispensable tool for achieving a passing score and advancing one's professional credentials.
Keywords:
APEA 3P Exam, Predictor Exam, Advanced Practice Nursing, Nurse Practitioner, Exam Prep, Verified Questions,
2026/2027
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a detailed rationale explaining why it is correct and why the other options are incorrect. Rationales are
written in a concise, evidence-based manner to enhance understanding and retention.
Compliance Checklist:
Aligned with the latest APEA 3P exam blueprint
Updated to reflect 2026/2027 clinical guidelines
All questions verified for accuracy and relevance
Page 1
, Rationales provided for every answer option
Suitable for self-assessment and focused review
Designed to simulate the actual exam experience
Content Area Overview:
Content Area Questions Key Topics Weight
Differential Diagnosis and 1-40 Symptom analysis, diagnostic reasoning, 20%
Clinical Reasoning evidence-based practice
Pharmacology and Prescriptive 41-80 Drug interactions, dosing, prescribing 20%
Authority regulations
Patient Assessment and 81-120 Physical exam, lab interpretation, imaging 20%
Diagnostic Testing
Management of Acute and 121-160 Treatment plans, follow-up care, patient 20%
Chronic Conditions education
Health Promotion and Disease 161-180 Screening, immunization, lifestyle 10%
Prevention counseling
Ethical and Legal Considerations 181-200 Informed consent, confidentiality, scope of 10%
in Practice practice
Page 2
,Q1. A 45-year-old construction worker presents with right shoulder pain and
weakness after a fall. On exam, you note atrophy of the supraspinatus and
infraspinatus muscles, and weakness with external rotation. Which additional finding
would most strongly support a diagnosis of suprascapular nerve entrapment rather
than a rotator cuff tear?
A. Positive drop arm test
B. Weakness with resisted abduction at 0 degrees
C. Normal electromyography (EMG) of the infraspinatus
D. Absence of tenderness over the bicipital groove
Correct Answer: B. Weakness with resisted abduction at 0 degrees
Rationale: Suprascapular nerve entrapment causes weakness in both abduction
(supraspinatus) and external rotation (infraspinatus), but the drop arm test (A) is more
indicative of a massive rotator cuff tear. EMG (C) would show denervation in nerve
entrapment, not normal. Bicipital groove tenderness (D) is associated with biceps
tendinopathy, not specific to either condition. Weakness with resisted abduction at 0
degrees reflects supraspinatus weakness, which is common in both, but the combination
with infraspinatus atrophy and external rotation weakness points to nerve entrapment.
Why Wrong:
A - Drop arm test is positive in full-thickness rotator cuff tears, not specific for nerve
entrapment.
C - EMG would be abnormal (showing denervation) in suprascapular nerve
entrapment.
D - Bicipital groove tenderness is not a distinguishing feature for either condition.
Reference: Bickley, L. (2025). Bates' Guide to Physical Examination, 14th Ed., Ch. 22.
Q2. A 32-year-old female presents with fatigue, weight gain, cold intolerance, and
constipation. Labs show TSH 0.1 mIU/L (low), free T4 0.6 ng/dL (low). Which
additional laboratory finding would most likely confirm the diagnosis of central
hypothyroidism?
A. Elevated thyroperoxidase antibodies
B. Low free T3
C. Low TSH response to TRH stimulation
D. Elevated thyroglobulin antibodies
Correct Answer: C. Low TSH response to TRH stimulation
Rationale: Central hypothyroidism is characterized by low TSH and low free T4 due to
pituitary or hypothalamic dysfunction. A blunted TSH response to TRH stimulation
confirms pituitary involvement, distinguishing it from primary hypothyroidism (where TSH
is high) or secondary to other causes. Elevated TPO antibodies (A) indicate autoimmune
thyroiditis (primary). Low free T3 (B) is non-specific. Elevated thyroglobulin antibodies
(D) also suggest autoimmune thyroid disease.
Page 3
, Why Wrong:
A - Elevated TPO antibodies are seen in Hashimoto's thyroiditis, a primary
hypothyroidism cause.
B - Low free T3 is common in any hypothyroidism and does not differentiate central
from primary.
D - Elevated thyroglobulin antibodies are also indicative of autoimmune thyroiditis,
not central hypothyroidism.
Reference: Jameson, J.L., & De Groot, L.J. (2025). Endocrinology: Adult and Pediatric,
8th Ed., Ch. 84.
Q3. A 58-year-old with type 2 diabetes and chronic kidney disease (eGFR 40 mL/min)
presents with a blood pressure of 158/92 mmHg. Current meds: metformin 1000 mg
BID, lisinopril 20 mg daily, amlodipine 5 mg daily. Which antihypertensive agent
would be most appropriate to add?
A. Hydrochlorothiazide 25 mg daily
B. Spironolactone 25 mg daily
C. Carvedilol 6.25 mg BID
D. Doxazosin 1 mg at bedtime
Correct Answer: B. Spironolactone 25 mg daily
Rationale: In patients with diabetes and CKD, spironolactone is a mineralocorticoid
receptor antagonist that reduces albuminuria and cardiovascular risk, and is effective in
resistant hypertension. Hydrochlorothiazide (A) is less effective when eGFR < 30-45
mL/min. Carvedilol (C) is not a first-line add-on for hypertension unless there is heart
failure. Doxazosin (D) is not preferred due to orthostatic hypotension and lack of renal
protection.
Why Wrong:
A - Thiazide diuretics lose efficacy at eGFR < 45 mL/min.
C - Beta-blockers are not first-line add-on agents for hypertension without compelling
indications.
D - Alpha-blockers are not preferred due to side effects and lack of renal benefit.
Reference: Whelton, P.K., et al. (2024). Hypertension Guideline Update, JACC.
Q4. A 67-year-old presents with acute onset of severe headache and vomiting. CT
head without contrast shows subarachnoid hemorrhage. Which of the following is the
most appropriate next step in management?
A. Lumbar puncture to confirm the diagnosis
B. CT angiography to identify a cerebral aneurysm
C. Initiate antiplatelet therapy to prevent ischemia
D. Administer tissue plasminogen activator (tPA)
Page 4